MRI在早期评价乳腺癌新辅助化疗效果中的应用  

MRI in predicting early changes of breast cancer during neoadjuvant chemotherapy

作　　者：杨英[1] 许卫[1] 李坤成[1] 

机构地区：[1]首都医科大学宣武医院医学影像学部放射科,北京100053

出　　处：《中国医学影像技术》2011年第7期1511-1514,共4页Chinese Journal of Medical Imaging Technology

摘　　要：新辅助化疗(NAC)已成为局部进展期乳腺癌(LABC)的标准治疗方法。正确评价LABC对NAC的反应,对进一步选择适当的手术方式、判断患者预后意义重大。评价乳腺癌NAC疗效的影像学方法主要有超声、乳腺X线摄影和MRI。本文综述MRI在早期评价乳腺癌NAC疗效中的作用。Neoadjuvant chemotherapy（NAC） is the standard treatment for locally advanced breast cancer（LABC）.Correct evaluation on the response of LABC to NAC plays an important role in further treatment and prognosis.The main medical imaging methods of evaluation on the efficacy of NAC include ultrasound,X-ray mammography and breast MRI.The early changes of breast cancer to NAC were reviewed in this article.

关 键 词：乳腺肿瘤 磁共振成像 新辅助化疗 

分 类 号：R737.9[医药卫生—肿瘤] R445.2[医药卫生—临床医学]